[go: up one dir, main page]

FR2710530B1 - Aqueous gel for nasal use, pellets, and their preparation process. - Google Patents

Aqueous gel for nasal use, pellets, and their preparation process.

Info

Publication number
FR2710530B1
FR2710530B1 FR9313714A FR9313714A FR2710530B1 FR 2710530 B1 FR2710530 B1 FR 2710530B1 FR 9313714 A FR9313714 A FR 9313714A FR 9313714 A FR9313714 A FR 9313714A FR 2710530 B1 FR2710530 B1 FR 2710530B1
Authority
FR
France
Prior art keywords
pellets
preparation process
aqueous gel
nasal use
nasal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9313714A
Other languages
French (fr)
Other versions
FR2710530A1 (en
Inventor
Phedon Zirinis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SLAMA GERARD
Original Assignee
SLAMA GERARD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9311589A external-priority patent/FR2710529A1/en
Application filed by SLAMA GERARD filed Critical SLAMA GERARD
Priority to FR9313714A priority Critical patent/FR2710530B1/en
Publication of FR2710530A1 publication Critical patent/FR2710530A1/en
Application granted granted Critical
Publication of FR2710530B1 publication Critical patent/FR2710530B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9313714A 1993-09-29 1993-11-17 Aqueous gel for nasal use, pellets, and their preparation process. Expired - Fee Related FR2710530B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9313714A FR2710530B1 (en) 1993-09-29 1993-11-17 Aqueous gel for nasal use, pellets, and their preparation process.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9311589A FR2710529A1 (en) 1993-09-29 1993-09-29 Aqueous gel for nasal use, pellets, and process for preparing them
FR9313714A FR2710530B1 (en) 1993-09-29 1993-11-17 Aqueous gel for nasal use, pellets, and their preparation process.

Publications (2)

Publication Number Publication Date
FR2710530A1 FR2710530A1 (en) 1995-04-07
FR2710530B1 true FR2710530B1 (en) 1995-12-22

Family

ID=26230640

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9313714A Expired - Fee Related FR2710530B1 (en) 1993-09-29 1993-11-17 Aqueous gel for nasal use, pellets, and their preparation process.

Country Status (1)

Country Link
FR (1) FR2710530B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN089295A0 (en) * 1995-02-02 1995-03-02 International Diabetes Institute Treatment of diabetic neuropathy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601923A1 (en) * 1986-01-23 1987-07-30 Behringwerke Ag NASAL APPLICABLE MEDICINE, METHOD FOR THE PRODUCTION AND USE THEREOF
EP0360340A1 (en) * 1988-09-19 1990-03-28 Akzo N.V. Composition for nasal administration containing a peptide
SE9003712L (en) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab GEL-PHARMACEUTICAL LIQUID COMPOSITION AND APPLICATION THEREOF IN PHARMACEUTICAL COMPOSITIONS

Also Published As

Publication number Publication date
FR2710530A1 (en) 1995-04-07

Similar Documents

Publication Publication Date Title
FI904419A7 (en) 3-(1-substituted-4-piperazinyl)-1H-indazoles, process for their preparation and their use as pharmaceuticals
FR2715843B1 (en) Sunscreen cosmetic compositions, preparation process and use.
CS29990A3 (en) Racemic or optically active bis-aza-bicyclic compounds, process forpreparing thereof, intermediates and use
EE9700044A (en) Heteroaryloxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds.
FI955942L (en) Disposable absorbent product intended for low viscosity secretions
ITMI921488A0 (en) GRANULES, PROCESS FOR THEIR PREPARATION AND THEIR USE
FI940810L (en) Substituted benzenesulfonylureas and thioureas, process for their preparation and their use as medicaments
FI902248A7 (en) N-heteroaryl-4-quinolineamines, process for their preparation and their use as pharmaceuticals
FI902850A7 (en) N-heteroarylpurin-6-amines, process for their preparation and their use as pharmaceuticals
DZ1910A1 (en) New streptogramins and method for preparing streptogramins by mutasynthesis.
AU2098395A (en) Predetermined dosage hypodermic syringe system
FR2702660B1 (en) Stabilized therapeutic compositions and process for their preparation.
EP0693507A3 (en) Curable liquid resin, process for its preparation and its use
BR9602337A (en) Compound process for its preparation uses the same process for treating arrhythmias and medication
ID18817A (en) 3-AMIDOCROMANILSULFONIL (IOP) UREA, PROCESS FOR MAKING, USE, AND PHARMACEUTICAL PROPERTIES WHICH CONTAINS IT
FI903818A7 (en) 1-(pyridinylamino)-2-pyrrolidones, process for their preparation and their use as pharmaceuticals
FI903214A7 (en) Naphthylamino- and naphthyloxy-pyrimidines and related compounds, process for their preparation and their use as dermatological drugs
ITTO940888A0 (en) CATIONIC POLYMER, FOR EXAMPLE OF SUPERABSORBENT TYPE, RELATED PROCESS AND USE.
ITTO940891A0 (en) CATIONIC POLYMER, FOR EXAMPLE OF SUPERABSORBENT TYPE, RELATED PROCESS AND USE.
GB2230262B (en) 2-substituted n,n-di-trimethoxybenzoyl piperazines and pharmaceutical uses thereof
FI971081L (en) Triazolopyridazines, process and intermediates for their preparation and their use as pharmaceuticals
FR2710530B1 (en) Aqueous gel for nasal use, pellets, and their preparation process.
FI903763A7 (en) 14-17a-etheno- and -ethaneoestratrienes, a process for preparing these compounds, and their use for preparing pharmaceuticals
KR960701075A (en) New 2'-methylidene nucleotide compound, preparation method thereof, and pharmaceutical use thereof [NOVEL 2'-METHYLIDENENUCLEOTIDE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL USE THEREOF]
FI956120A0 (en) Propylene polymer, process for its preparation and its use

Legal Events

Date Code Title Description
ST Notification of lapse